Status:
COMPLETED
Impact Study on Cerecare Compression Garments in the Treatment of Ehlers-Danlos Syndromes
Lead Sponsor:
Cerecare
Conditions:
Eds, Unspecified Type
Eligibility:
All Genders
16+ years
Brief Summary
EDS (Ehlers-Danlos syndromes) form a heterogeneous group of hereditary connective tissue pathologies, which present a characteristic triad: cutaneous hyperelasticity, articular hyperlaxity and connect...
Eligibility Criteria
Inclusion
- Ehlers-Danlos syndrome diagnosis confirmed by a medical specialist, according to the new diagnostic criteria of 2017,
- Articular hyperlaxity,
- Have not used compression garments for at least 1 year,
- Without expected body weight change within 6 months,
- Having agreed to participate in the study
Exclusion
- Presenting a known allergy to the components of compression garments,
- Presenting acute and unusual pain, not medically controlled,
- Pregnant woman,
- Participating simultaneously with another study or having recently participated in another study for which the exclusion period would not be completed.
Key Trial Info
Start Date :
May 22 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2021
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT03451188
Start Date
May 22 2018
End Date
November 30 2021
Last Update
December 13 2021
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr Pontier
Clermont-Ferrand, France, 63100
2
Dr Benistan
Garches, France, 92380
3
Dr Michot
Paris, France, 75015
4
Dr Enjalbert
Perpignan, France